Mallinckrodt Announces U.S. FDA Approval of Supplemental New …
https://ir.mallinckrodt.com/news-releases/news-release-details/mallinckrodt-announces-us-fda-approval-supplemental-new-drug
WebDUBLIN, March 1, 2024 /PRNewswire/ -- Mallinckrodt plc, a global specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Mallinckrodt's supplemental New Drug Application (sNDA) for the Acthar ® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™ Injector (herein ...
DA: 92 PA: 20 MOZ Rank: 25